%PDF-1.4
%
29 0 obj
<>
endobj
26 0 obj
<>
endobj
99 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-09-09T13:49:28Z
2024-03-28T17:29:08-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T17:29:08-07:00
application/pdf
Heather
2002-843.oct
uuid:0c8ac9cf-1dd2-11b2-0a00-ba08277d8900
uuid:0c8ac9d1-1dd2-11b2-0a00-d30000000000
endstream
endobj
15 0 obj
<>
endobj
16 0 obj
<>
endobj
30 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 7 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 9 0 R/Type/Page>>
endobj
106 0 obj
[110 0 R]
endobj
107 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
0.0134 Tc 0.3625 Tw 10 0 0 10 54 713.1616 Tm
[(concentrations were )-4.1 (normal. Blood, throat, and urine)]TJ
-0.00011 Tc 0.02499 Tw 0 -1.2 TD
(cultures were negative.)Tj
0.1441 Tw 1.2 -1.2 Td
(Skin biopsy revealed extravasation of erythrocytes and)Tj
0.23151 Tw -1.2 -1.2 Td
[(perivascular inflammation. )54.8 (Although perivascular inflam-)]TJ
-0.02299 Tw T*
(mation consisted of intact neutrophils and eosinophils, some)Tj
0.01759 Tw T*
(neutrophil fragments were also seen, which is characteristic)Tj
0.05499 Tw T*
[(for leukocytoclasis. )17.7 (The biopsy also showed minimal to no)]TJ
0.27361 Tw T*
[(fibrin in vessel walls. )17.7 (These pathological findings were)]TJ
0.0199 Tc 0.39439 Tw T*
(consistent with mild vasculitis \(Figure 2\). Immuno-)Tj
-0.00011 Tc 0.2093 Tw T*
(fluorescence showed deposits of IgM and C3 within the)Tj
0.02499 Tw T*
(small vessel walls.)Tj
0.0051 Tw 1.2 -1.2 Td
(He was diagnosed with azithromycin induced leukocyto-)Tj
0.0199 Tc 0.6942 Tw -1.2 -1.2 Td
[(clastic vasculitis \(LCV\). )54.8 (After discontinuation of)]TJ
-0.00011 Tc -0.0067 Tw T*
(azithromycin, body temperature returned to normal within 4)Tj
0.1431 Tw T*
(days, and purpura began to fade dramatically on the next)Tj
0.02499 Tw T*
(day and disappeared within 3 days.)Tj
0.18559 Tw 1.2 -1.2 Td
[(LCV)-417.9 (is considered a type III hypersensitivity reaction)]TJ
0.0199 Tc 0.5466 Tw -1.2 -1.2 Td
(that is characterized by perivascular inflammation,)Tj
-0.00011 Tc -0.0217 Tw T*
(secondary ischemic changes, and necrosis)Tj
0 Tc 0 Tw 6.5 0 0 6.5 221.1083 500.4616 Tm
(1)Tj
-0.00011 Tc -0.0394 Tw 10 0 0 10 224.3582 497.1616 Tm
[(. The )-17.7 (relationship)]TJ
-0.0211 Tw -17.0358 -1.2 Td
(between drugs and vasculitis has been reported)Tj
0 Tc 0 Tw 6.5 0 0 6.5 240.9835 488.4616 Tm
(2)Tj
-0.00011 Tc -0.02119 Tw 10 0 0 10 244.2335 485.1616 Tm
(. Macrolides)Tj
0.0414 Tw 7.3766 22.8 Td
(are a group of antibacterial agents frequently used in child-)Tj
-0.0331 Tw T*
[(hood. )54.8 (Aller)17.7 (gy to macrolides is extremely rare \(0.4% to 3%\))]TJ
0 Tc 0 Tw 6.5 0 0 6.5 552.25 704.4616 Tm
(3)Tj
10 0 0 10 555.4999 701.1616 Tm
(.)Tj
-0.00011 Tc 0.1675 Tw -23.75 -1.2 Td
[(W)79.9 (e considered that our patient\325)54.8 (s cutaneous findings were)]TJ
0.3349 Tw T*
(related to azithromycin therapy because his complaints)Tj
0.07809 Tw T*
(started after therapy was begun and disappeared after drug)Tj
0.1907 Tw T*
[(discontinuation. )54.8 (A)-385.8 (single case with azithromycin induced)]TJ
0.02499 Tw T*
[(LCV)-257.3 (has been reported)]TJ
0 Tc 0 Tw 6.5 0 0 6.5 411.5845 644.4615 Tm
(4)Tj
10 0 0 10 414.8345 641.1616 Tm
(.)Tj
-0.00011 Tc 0.0361 Tw -8.4835 -1.2 Td
(Our case showed that azithromycin, an antibiotic widely)Tj
0.02499 Tw -1.2 -1.2 Td
[(prescribed in childhood, may lead to LCV)128.8 (.)]TJ
/T1_1 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES)Tj
/T1_0 1 Tf
0.02499 Tw 8 0 0 8 325 583.1616 Tm
[(1.)-875.1 (Grunwald MH, Shriker O, Halevy S, )54.8 (Alkan M, Levy R. Impaired)]TJ
1.675 -1.25 Td
(neutrophil functions in patients with leukocytoclastic vasculitis. Int)Tj
0 -1.25 TD
(J Dermatol 1997;36:509-13.)Tj
-1.675 -1.25 Td
[(2.)-875.1 (T)69.9 (en Holder SM, Joy MS, Falk RJ. Cutaneous and systemic )]TJ
1.675 -1.25 Td
[(manifestations of drug-induced vasculitis. )54.8 (Ann Pharmacother)]TJ
0 Tc 0 Tw T*
(2002;36:130-47.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(3.)-875.1 (Demoly P)110.7 (, Benahmed S, )17.7 (V)110.8 (alembois M, et al. )54.8 (Aller)17.7 (gy to macrolide)]TJ
1.675 -1.25 Td
(antibiotics. Review of the literature. Presse Med 2000;29:321-6.)Tj
-1.675 -1.25 Td
[(4.)-875.1 (Gavura SR, Nusinowitz S. Leukocytoclastic vasculitis associated)]TJ
1.675 -1.25 Td
[(with clarithromycin. )54.8 (Ann Pharmacother 1998;32:543-5.)]TJ
ET
0 0 0 0 k
420 777 137 -27 re
f*
408 770 150 -25 re
f*
0 0 0 1 K
54 54 m
558 54 l
S
BT
0 0 0 1 k
/T1_2 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(Odemis, et al: )17.7 (Azithr)36.8 (omycin-induced LCV)]TJ
0 Tc 0 Tw 60.9375 -0.0313 Td
(2293)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.09 396.48 -10.84 re
f*
0.5 w
109.22 59.09 396.48 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
9 0 obj
<>stream
8;Z\tN=NiK#_[L'(Z]_)-sBTsqU6csmRrkUN?3;\`XKY\TItEqCot6[looGNAF!Ye
UKQi'Z*YR0BXcg?aCT)_Gu_)9@6Z"&[p*&7>?K01_XSka]n5!BDaYEtZnQ";+!ROA
L*Bc\FH!D'o:h^$_sRJ*f@=EhDF@qKo#+r-P-E@j4f^hj^rlr(AHrBeq4imT]?PT,
<2j&^f7&k#,h]_DgTc[2j=>#b1L%R%Wl@&9<+,[\:s5I[zz!'Uq<
F$sQ3GV!,W(X>.rkrDuJc#3UA?U$O~>
endstream
endobj
13 0 obj
[/Indexed/DeviceRGB 255 12 0 R]
endobj
12 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
34 0 obj
<>
endobj
4 0 obj
<>
endobj
38 0 obj
<>
endobj
68 0 obj
<>
endobj
105 0 obj
<>
endobj
37 0 obj
<>
endobj
49 0 obj
<>stream
HS{PSW˽Y.%wj}UWdHG !A$@pC" "P`]Xunh2[v{nzG;Ι7!(|oخ=+Bd^i\ U]0Pf1pt[
x3<υm({oGU\:z@W^
Eٕ7)T)RjE/77ozkիq6nv$ADJ "qH''l%|q+;;1%PqTƉ(Q"I|j*.#qHL \}YD(z_}ud!~nY d%F@Y o!FyAv>9!Q(%)!86"P?T2nnmE`7aO̎c;_Υ=y̓s3Dq\Gg=M\ol1)%zeEԺp`@Wyrv'bڹ&=
9גJ'
qftܔ\hY1ŧ-jSS99`T#)&`=Ɗ˼
yKYYZh*ϴ\o[M`?t
0,NJΣ`0ߒ
}nh89&Jj$zyaI^`oBAnBd\8aڤzW-K5k=
e&#v`ۥf]_Хg6t
6GA%ƻ *'3}s^^j圡˃J!i:TXyæ.Y
EG5_6wQMQ`u>9HS2NL^I<ໟ*p$pb
ֻND')]2^M\Oθ%J)vXy`d
-]5
J)i<.! nfјs3,TI*icbYpaa$U
۪F:S7?hd+֩s=)vvo
MY@E.ik+sr)3 1y(.G͖*C-w&jePA<ț)&feXxg7_\1HðKCe{Pe3:6]aMΗXK{ c咚ܧo9 FӘ1`fC0լ LU,:/͕$뢹ЇHWyu8ٝi7u\rvDo-$W_'o`S!$ɯ\7b}Y'G["F_7[QMtsp_K~4Qi`G/AзAxF4(6vj{7\x 0v\FW
et}qHVjG3Dr{\A&@JL87ߩ\4KVq3]i@g%zA+N/ Myk=6`W6`YMA06,f:?V;d0wF[#9̅՛%}>Z?qqH\'p@+j¯D@O2n~L'Iɺ-hhw`x빺MyZmXydVաg6B+S7I[_1M6Vty@XRkMe6S5|RծR]J[pNV78]rU0U56G}g7֦n\Z1.!|L
[hDP DKPh)m>P(Oe(@I|-K[vQf?sFX&?cZ:+2-݃"}0t$V毓ѡҐtNjU{Xũm}[! 6r۪N˜yVRƢ5Y@q5֎8Ui; *,A0x6L#ìcjqQgV?m4VwU6;{wr!j1_a錾ʓeƒl\A`/]wiEl+Rf0c@N&r~,4A
0m:ce|8:z!-+sd4v̾SIM,=!BH%5q2OMFcyC\e*m19%\ַTW&YKjVGw\I#=
G! wt4,ܜUJL2D^:Tzg&J%5RO{4EVj(ZNoN4ZM\Νߎ#DMɃl4\
]28
&BMi_X2dGP=8c҄zUjMim1t$s |Aڂ73Xt2stS^$s6N=0\Ol u85?1gcl/_|!ޑЙ'oX+[`X4vvWU9vTHۙ$IXD>)Ǯ !:1b61w'BJFW]1xo?|gtu
YHt[,=e9F1MM!a|Ag'zin˅xS(.Ey1vp|;6=K3V~r@Xx5`9a$$pudG0^UK
q\igڔxraTxlφ-g*+~#a֩*5c6kF#vlIAQY,%rTvutQ:.W#ܹ]YDgcpUW:NseM{ŭ擷y]丨'62])>v?d
!mb s6Q
2ٚlXo~hcg0z-Ԃ-E
h8#O_ IiHBJK.PG}9-}jk[&K- _UEЏ,¹MkBDWȕM%
oY
7:,%ѠJjr$2Q4XϚ-WF1TGQEhRieH6r\M!KI\